Nanox.AI
AI-powered medical imaging analysis and diagnostic support
Company profile
Company profile
Nanox is a medical imaging technology company focused on democratizing access to diagnostic imaging worldwide. The company has developed the Nanox.ARC, a novel digital X-ray system that utilizes proprietary silicon-based MEMs X-ray source technology. This innovative approach aims to reduce the cost and complexity of traditional X-ray equipment, making medical imaging more accessible in underserved markets and remote locations. Nanox combines its hardware innovations with cloud-based AI solutions through the Nanox.CLOUD platform, which provides radiologists and healthcare providers with tools for image management, analysis, and interpretation. The company's vision centers on creating a global network of accessible imaging services, particularly targeting regions with limited access to diagnostic imaging infrastructure. By integrating advanced imaging hardware with AI-powered software solutions, Nanox seeks to address the global shortage of radiologists and improve early disease detection capabilities. The company serves healthcare systems, imaging centers, and medical facilities seeking cost-effective alternatives to conventional X-ray and CT scanning equipment.
Company description Nanox official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas · On Premise deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered medical imaging analysis and diagnostic support
Digital X-ray system with novel cold-cathode technology
Cloud-based medical imaging repository and AI platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of colloid and interface science · Sep 15, 2026
Programmable Vacancy Topology in High-Entropy-Alloy-Inspired Multiprincipal Alloys Directs Ru-Centered Alkaline Hydrogen Evolution.Journal of the American Chemical Society · Aug 19, 2026
Inkjet-Printed SiOxNy Barrier Film for Encapsulation of Perovskite Solar Cells.Small (Weinheim an der Bergstrasse, Germany) · Jul 25, 2026
Reconfigurable Nonvolatile Photodetectors for Brain-Inspired Vision.ACS nano · Jul 23, 2026
A symbiotic skin hydrogel interface enabled by flexible hydrogel network with embedded enhancement structure.Nature communications · Jul 10, 2026
In Situ Insights into the Formaldehyde Sensing Mechanism of SnO2/NiO: The Critical Role of Lattice Oxygen.ACS sensors · Jul 10, 2026
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Nanox's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.